Erasca, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ERAS Nasdaq 2836 www.erasca.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Erasca, Inc.

Discovering Opportunities: AirJoule Technologies Among 3 Promising Penny Stocks - Dec 12th, 2025 5:04 am
Analyst Confidence High in Erasca (ERAS) Amid Pipeline Advancement and Earlier Q3 2025 Results - Nov 28th, 2025 11:26 pm
Erasca to Present at the 8th Annual Evercore Healthcare Conference - Nov 25th, 2025 7:08 am
3 Promising Penny Stocks With Market Caps As Low As $200M - Nov 13th, 2025 5:05 am
Erasca Reports Third Quarter 2025 Business Updates and Financial Results - Nov 12th, 2025 2:01 pm
Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015 - Nov 6th, 2025 6:00 am
Erasca to Present at Upcoming Conferences in November - Nov 4th, 2025 6:00 am
Discovering Potential: IZEA Worldwide And 2 Other Top Penny Stocks - Oct 13th, 2025 6:05 am
Spotlight On September 2025's Promising Penny Stocks - Sep 12th, 2025 12:05 pm
Erasca to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - Sep 2nd, 2025 6:00 am
Promising Penny Stocks To Consider In August 2025 - Aug 14th, 2025 6:05 am
Erasca Reports Second Quarter 2025 Business Updates and Financial Results - Aug 12th, 2025 2:01 pm
Top Penny Stocks To Watch In July 2025 - Jul 3rd, 2025 12:05 pm
Erasca Announces IND Clearance for Potential First-in-Class and Best-in-Class Pan-KRAS Inhibitor ERAS-4001 - Jun 2nd, 2025 6:00 am
Discover May 2025's Top Penny Stocks - May 30th, 2025 6:05 am
Erasca to Present at Upcoming Investor Conferences in June - May 29th, 2025 6:00 am
Erasca Reports First Quarter 2025 Business Updates and Financial Results - May 13th, 2025 2:05 pm
Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway - May 13th, 2025 6:00 am
Erasca to Present at the Bank of America Securities Health Care Conference - May 7th, 2025 6:00 am
Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting - Apr 29th, 2025 2:05 pm